| 1 |
Akiyoshi M, Kakei M, Nakazaki M, Tanaka H (1995) A new hypoglycemic agent, A-4166, inhibits ATP-sensitive potassium channels in rat pancreatic beta-cells. Am J Physiol 268:E185–E193 |
미소장 |
| 2 |
Box GEP, Behnken DW (1960) Some new three level designs for the study of quantitative variables. Technometrics 2:455–475 |
미소장 |
| 3 |
Davis SS, Hardy JG, Taylor MJ, Whalley DR, Willson CG (1984) A comparative study of gastrointestinal transit of a pellet and tablet formation. Int J Pharm 21:167–177 |
미소장 |
| 4 |
Fujitani S, Yada T (1994) A novel D-phenylalanine-derivative hypoglycemic agent A-4166 increases cytosolic free Ca2? in rat pancreatic beta-cells by stimulating Ca2? influx. Endocrinology 134:1395–1400 |
미소장 |
| 5 |
Gohel MC, Amin AF (1998) Formulation optimization of controlled release diclofenac sodium microspheres using factorial design. J Control Release 51:115–122 |
미소장 |
| 6 |
Guyot M, Fawaz F (1998) Nifedipine loaded-polymeric microspheres:preparation and physical characteristics. Int J Pharm 175:61–74 |
미소장 |
| 7 |
Ikenoue T, Akiyoshi M, Fujitani S, Okazaki K, Kondo N, Maki T (1997) Hypoglycemic and insulinotropic effects of a novel oral antidiabetic agent ()-N-(trans-4-sopropylcyclohexanecarbonyl)-D-phenylalanine (A-4166). Br J Pharmacol 120:137–145 |
미소장 |
| 8 |
Keilson L, Mather S, Walter YH, Subramanian S, Mcleod JF (2000) Determination of nateglinide in human plasma by highperformance liquid chromatography with pre-column derivatization using a coumarin-type fluorescent reagent. J Clin Endocrinol Metab 85:1081 |
미소장 |
| 9 |
Li S, Lin S, Chien YW, Daggy BP, Mirchandani HL (2001) Statistical optimization of gastric floating system for oral controlled delivery of calcium. AAPS Pharm Sci Tech 2: article 1 |
미소장 |
| 10 |
Naik JB, Deshmukh RK, Kamle VV (2013) Development of sustained released microparticles of Diclofenac sodium using polymer complex by spray drier. AJPTR 3:892–904 |
미소장 |
| 11 |
Nateglinide tablets. US FDA label. http://www.accessdata.fda.gov/drugsatfda_docs/label/2011/021204s014lbl.pdf |
미소장 |
| 12 |
Nazzal S, Khan MA (2002) Response surface methodology for the optimization of ubiquinone self-nanoemulsified drug delivery system. AAPS Pharm Sci Tech 3: article 3 |
미소장 |
| 13 |
Shinkai H, Toi H, Kumashiro I, Seto Y, Fukuma M, Dan K, Toyoshima SN (1988) Acylphenylalanines and related compounds. A new class of oral hypoglycemic agents. J Med Chem 31:2092–2097 |
미소장 |
| 14 |
Subhedar P, Naik JB, Muley DN (2010) Effect of polymer concentration on sustained release microparticles of metformin hydrochloride prepared by using spray dryer. Polym Plast Eng Technol 49:267–271 |
미소장 |
| 15 |
Takesada H, Matsuda K, Ohtake R (1996) Structure determination of metabolites isolated from urine and bile after administration of AY4166, a novel D-phenylalanine derivative hypoglycemic agent. Bioorg Med Chem 4:1771–1781 |
미소장 |
| 16 |
Weaver ML, Orwig BA, Rodriguez LC (2001) Pharmacokinetics and metabolism of nateglinide in humans. Drug Metab Dispos 29:415–421 |
미소장 |
| 17 |
AAPS PharmSciTech volume 7, issue 4—Editorial  |
미소장 |